Valuation: Convatec Group PLC

Market Cap 5.99B 5.26B 4.91B 4.51B 8.44B 574B 8.64B 58.23B 22.77B 284B 22.48B 21.99B 981B P/E 2026 *
21.7x
P/E 2027 * 17x
Enterprise Value 7.19B 6.32B 5.89B 5.41B 10.13B 688B 10.38B 69.9B 27.34B 341B 26.98B 26.4B 1,178B EV / Sales 2026 *
2.8x
EV / Sales 2027 * 2.57x
Free-Float
95.19%
Yield 2026 *
2.56%
Yield 2027 * 2.87%
1 day+1.31%
1 week+5.47%
Current month+9.11%
1 month+8.82%
3 months+9.11%
6 months-2.37%
Current year-5.59%
1 week 11.41
Extreme 11.411
12.34
1 month 11.14
Extreme 11.14
12.34
Current year 10.45
Extreme 10.45
14.09
1 year 10.45
Extreme 10.45
14.09
3 years 9.9
Extreme 9.9
16.65
5 years 8.69
Extreme 8.69
16.65
10 years 0
Extreme 0
18.52
Manager TitleAgeSince
Chief Executive Officer 62 04/08/2025
Director of Finance/CFO 51 04/08/2025
Chief Operating Officer - 01/06/2026
Director TitleAgeSince
Director/Board Member 71 14/08/2017
Chairman 78 30/09/2019
Director/Board Member 62 02/03/2020
Change 5-day change 1-year change 3-year change Capi.($)
+1.31%+5.47% - - 5.99B
+0.68%+7.39%-15.63%-4.20% 187B
+0.76%+6.90%-5.30%-0.80% 112B
-0.30%+6.00%+9.95%+70.78% 61.99B
+0.32%-4.03%+25.94%+44.22% 48.52B
+1.24%+9.95%-7.67%-39.93% 46.4B
-1.06%+7.80% - - 33.89B
+0.39%+5.19%-15.90%-43.24% 28.99B
+0.14%-5.85%+33.42%-7.66% 23.75B
+1.95%+11.52%+2.83%+2.08% 22.89B
Average +0.45%+4.36%+3.45%+2.66% 62.82B
Weighted average by Cap. +0.34%+5.54%-3.01%+4.55%

Financials

2026 *2027 *
Net sales 2.57B 2.25B 2.1B 1.93B 3.62B 246B 3.7B 24.96B 9.76B 122B 9.63B 9.42B 420B 2.74B 2.41B 2.25B 2.06B 3.86B 262B 3.95B 26.62B 10.41B 130B 10.28B 10.05B 449B
Net income 275M 242M 226M 207M 388M 26.35B 397M 2.68B 1.05B 13.04B 1.03B 1.01B 45.08B 354M 311M 290M 266M 499M 33.89B 511M 3.44B 1.35B 16.77B 1.33B 1.3B 57.98B
Net Debt 1.2B 1.05B 984M 903M 1.69B 115B 1.73B 11.67B 4.56B 56.86B 4.5B 4.41B 197B 1.03B 909M 848M 779M 1.46B 99.07B 1.49B 10.06B 3.93B 49.03B 3.88B 3.8B 169B
Logo Convatec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,910
Date Price Change Volume
29/07/26 $12.34 +1.31% 85,530
28/07/26 $12.18 +2.70% 12,274
27/07/26 $11.86 +1.37% 31,316
24/07/26 $11.70 +2.63% 16,448
23/07/26 $11.40 -2.56% 19,240
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
3.064USD
Average target price
3.986USD
Spread / Average Target
+30.12%

Quarterly revenue - Rate of surprise